scispace - formally typeset
Search or ask a question
Institution

University of Illinois at Chicago

EducationChicago, Illinois, United States
About: University of Illinois at Chicago is a education organization based out in Chicago, Illinois, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 57071 authors who have published 110536 publications receiving 4264936 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The MDRD Study equation provides unbiased and reasonably accurate estimates across a wide range of subgroups when eGFR is <60 ml/min per 1.73 m(2), and in individual patients, interpretation of GFR estimates should be interpreted with caution to avoid misclassification of chronic kidney disease in the context of the clinical setting.
Abstract: Glomerular filtration rate (GFR) estimates facilitate detection of chronic kidney disease. Performance of the Modification of Diet in Renal Disease (MDRD) Study equation varies substantially among populations. To describe the performance of the equation in a large, diverse population, estimated GFR (eGFR) was compared to measured GFR (mGFR) in a cross-sectional analysis of 5504 participants in 10 studies that included measurements of standardized serum creatinine and urinary clearance of iothalamate. At eGFR or =60 ml/min per 1.73 m(2). The accuracy of the equation, measured by the percent of estimates that fell within 30% of mGFR, was similar for eGFR values above or below 60 ml/min per 1.73 m(2) (82% and 84%, respectively). Differences in performance among subgroups defined by age, sex, race, diabetes, transplant status, and body mass index were small when eGFR was <60 ml/min per 1.73 m(2). The MDRD Study equation therefore provides unbiased and reasonably accurate estimates across a wide range of subgroups when eGFR is <60 ml/min per 1.73 m(2). In individual patients, interpretation of GFR estimates near 60 ml/min per 1.73 m(2) should be interpreted with caution to avoid misclassification of chronic kidney disease in the context of the clinical setting.

549 citations

Journal ArticleDOI
TL;DR: The American Society of Regional Anesthesia and Pain Medicine Practice Advisory on Local Anesthetic Systemic Toxicity assimilates and summarizes current knowledge regarding the prevention, diagnosis, and treatment of this potentially fatal complication.

549 citations

Journal ArticleDOI
01 Aug 2008-Stroke
TL;DR: This commentary reviews key epidemiological aspects of LAICOD and suggests approaches to treatment such as antithrombotic therapies, revascularization procedures, and counterpulsation devices hold promise.
Abstract: Background and Purpose—Large artery intracranial occlusive disease (LAICOD) is a common and important stroke subtype. In this commentary, we review key epidemiological aspects of LAICOD. Summary of Review— LAICOD has emerged as the most common stroke subtype worldwide and is associated with a high risk of recurrent stroke. Hypotheses have been proposed to explain causation, which include such factors as traditional cardiovascular risk factors, high blood volume states, and genetic abnormalities. Approaches to treatment such as antithrombotic therapies, revascularization procedures, and counterpulsation devices hold promise. Conclusions—LAICOD poses a major stroke problem worldwide and is likely the most common stroke subtype. The etiology and treatment of this disorder remain poorly defined. International collaborations are needed to pool collective knowledge and develop definitive studies to better understand causation and treatment of LAICOD. (Stroke. 2008;39: 2396-2399.)

549 citations

Journal ArticleDOI
TL;DR: Although ACE was first considered to be a carboxypeptidase-type enzyme, its actions go beyond cleaving dipep-tides from the free C-terminal end of peptide substrates, some of the basic properties of this enzyme remain unexplained.
Abstract: Many of the properties of angiotensin I converting enzyme or kininase II (ACE) have been discussed in extenso in the literature. The mode of action of ACE inhibitors has been studied in experimental animals and used clinically in millions of patients. The relatively few side effects have also been amply scrutinized. Nevertheless, some of the basic properties of this enzyme remain unexplained. For instance, although ACE was first considered to be a carboxypeptidase-type enzyme (peptidyl dipeptidase or dipeptidyl carboxypeptidase) (1,2) its actions go beyond cleaving dipep-tides from the free C-terminal end of peptide substrates. ACE inactivates substance P in spite of its blocked C-terminus, primarily by releasing the C-terminal tripeptide Gly-Leu-Met-NH2 (3). The blocked C-terminal tripep-tide, Arg-Pro-Gly-NH2, is also released from the luteinizing hormone releasing hormone (LHRH) (A). ACE, surprisingly, also cleaves the protected the N-terminal tripeptide

548 citations

Journal ArticleDOI
TL;DR: Although non-heterosexual orientation was generally associated with a higher risk of substance use and substance dependence, the majority of sexual minority respondents did not report substance use or meet criteria for DSM-IV substance dependence.
Abstract: Aims To assess past-year prevalence rates of substance use behaviors and substance dependence across three major dimensions of sexual orientation (identity, attraction and behavior) in a large national sample of adult women and men in the United States. Design Data were collected from structured diagnostic face-to-face interviews using the Alcohol Use Disorder and Associated Disabilities Interview Schedule DSM-IV version IV (AUDADIS-IV). Setting Prevalence estimates were based on data collected from the 2004–2005 (wave 2) National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Participants A large national sample of 34 653 adults aged 20 years and older: 52% female, 71% white, 12% Hispanic, 11% African American, 4% Asian and 2% Native American. Findings Approximately 2% of the population self-identified as lesbian, gay or bisexual; 4% reported at least one life-time same-sex sexual partner and 6% reported same-sex sexual attraction. Although non-heterosexual orientation was generally associated with a higher risk of substance use and substance dependence, the majority of sexual minority respondents did not report substance use or meet criteria for DSM-IV substance dependence. There was considerable variation in substance use outcomes across sexual orientation dimensions; these variations were more pronounced among women than among men. Conclusions Results support previous research findings of heightened risk of substance use and substance dependence among some sexual minority groups and point to the need for research that examines the reasons for such differences. Results also highlight important gender differences and question previous findings indicating uniformly higher risk for substance dependence among sexual minorities. Risks appear to vary based on gender and how sexual orientation is defined. Findings have implications for more effective prevention and intervention efforts that target subgroups at greatest risk.

547 citations


Authors

Showing all 57433 results

NameH-indexPapersCitations
Meir J. Stampfer2771414283776
Frank B. Hu2501675253464
Lewis C. Cantley196748169037
Ronald Klein1941305149140
Anil K. Jain1831016192151
Yusuke Nakamura1792076160313
Bruce M. Spiegelman179434158009
Jie Zhang1784857221720
D. M. Strom1763167194314
Yury Gogotsi171956144520
Todd R. Golub164422201457
Rodney S. Ruoff164666194902
Philip A. Wolf163459114951
Barbara E.K. Klein16085693319
David Jonathan Hofman1591407140442
Network Information
Related Institutions (5)
University of Minnesota
257.9K papers, 11.9M citations

97% related

University of Pennsylvania
257.6K papers, 14.1M citations

97% related

University of Michigan
342.3K papers, 17.6M citations

96% related

Columbia University
224K papers, 12.8M citations

96% related

Johns Hopkins University
249.2K papers, 14M citations

96% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023112
2022582
20215,602
20205,335
20194,825
20184,520